Amphastar pharmaceuticals reports financial results for the three months ended june 30, 2024

Reports net revenues of $182.4 million for the three months ended june 30, 2024 rancho cucamonga, ca / accesswire / august 7, 2024 / amphastar pharmaceuticals, inc. (nasdaq:amph) ("amphastar" or the "company") today reported results for the three months ended june 30, 2024. second quarter highlights net revenues of $182.4 million for the second quarter gaap net income of $37.9 million, or $0.73 per share, for the second quarter adjusted non-gaap net income of $48.7 million, or $0.94 per share, for the second quarter dr. jack zhang, amphastar's president and chief executive officer, commented: "as we finish another strong quarter, amphastar has continued its impressive performance with solid sales growth.
AMPH Ratings Summary
AMPH Quant Ranking